A detailed history of Atria Investments LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Atria Investments LLC holds 43,183 shares of RPRX stock, worth $1.05 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
43,183
Previous 50,822 15.03%
Holding current value
$1.05 Million
Previous $1.34 Million 8.88%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$25.63 - $29.27 $195,787 - $223,593
-7,639 Reduced 15.03%
43,183 $1.22 Million
Q2 2024

Aug 13, 2024

BUY
$26.26 - $29.9 $309,946 - $352,909
11,803 Added 30.25%
50,822 $1.34 Million
Q1 2024

May 21, 2024

BUY
$27.46 - $31.33 $1.07 Million - $1.22 Million
39,019 New
39,019 $1.19 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.